Is There an Effect of Ghrelin/ghrelin Analogs on Cancer? A Systematic Review

Overview

Journal Endocr Relat Cancer

Specialties Endocrinology
Oncology

Date 2016 Aug 25

PMID 27552970

Citations 25

Authors

Sakine Sever

Donna L White

Jose M Garcia

Affiliations

Soon will be listed here.

Abstract

Ghrelin is a hormone with multiple physiologic functions, including promotion of growth hormone release, stimulation of appetite and regulation of energy homeostasis. Treatment with ghrelin/ghrelin-receptor agonists is a prospective therapy for disease-related cachexia and malnutrition. In vitro studies have shown high expression of ghrelin in cancer tissue, although its role including its impact in cancer risk and progression has not been established. We performed a systematic literature review to identify peer-reviewed human or animal in vivo original research studies of ghrelin, ghrelin-receptor agonists, or ghrelin genetic variants and the risk, presence, or growth of cancer using structured searches in PubMed database as well as secondary searches of article reference lists, additional reviews and meta-analyses. Overall, 45 (73.8%) of the 61 studies reviewed, including all 11 involving exogenous ghrelin/ghrelin-receptor agonist treatment, reported either a null (no statistically significant difference) or inverse association of ghrelin/ghrelin-receptor agonists or ghrelin genetic variants with cancer risk, presence or growth; 10 (16.7%) studies reported positive associations; and 6 (10.0%) reported both negative or null and positive associations. Differences in serum ghrelin levels in cancer cases vs controls (typically lower) were reported for some but not all cancers. The majority of in vivo studies showed a null or inverse association of ghrelin with risk and progression of most cancers, suggesting that ghrelin/ghrelin-receptor agonist treatment may have a favorable safety profile to use for cancer cachexia. Additional large-scale prospective clinical trials as well as basic bioscientific research are warranted to further evaluate the safety and benefits of ghrelin treatment in patients with cancer.

Citing Articles

Malignancies in Prader-Willi Syndrome: Results From a Large International Cohort and Literature Review.

Pellikaan K, Nguyen N, Rosenberg A, Coupaye M, Goldstone A, Hoybye C J Clin Endocrinol Metab. 2023; 108(12):e1720-e1730.

PMID: 37267430 PMC: 10655548. DOI: 10.1210/clinem/dgad312.

EXT418, a novel long-acting ghrelin, mitigates Lewis lung carcinoma induced cachexia in mice.

Kerr H, Krumm K, Lee I, Anderson B, Christiani A, Strait L J Cachexia Sarcopenia Muscle. 2023; 14(3):1337-1348.

PMID: 36942661 PMC: 10235874. DOI: 10.1002/jcsm.13211.

Colon Cancer and Obesity: A Narrative Review.

Duraiyarasan S, Adefuye M, Manjunatha N, Ganduri V, Rajasekaran K Cureus. 2022; 14(8):e27589.

PMID: 36059323 PMC: 9433794. DOI: 10.7759/cureus.27589.

Role of the Ghrelin System in Colorectal Cancer.

Kasprzak A Int J Mol Sci. 2022; 23(10).

PMID: 35628187 PMC: 9141034. DOI: 10.3390/ijms23105380.

Sarcopenia and Ghrelin System in the Clinical Outcome and Prognosis of Gastroenteropancreatic Neuroendocrine Neoplasms.

Herrera-Martinez Y, Alzas Teomiro C, Leon Idougourram S, Molina Puertas M, Calanas Continente A, Serrano Blanch R Cancers (Basel). 2022; 14(1).

PMID: 35008278 PMC: 8750458. DOI: 10.3390/cancers14010111.

References

Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M . Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab. 2001; 85(12):4908-11. DOI: 10.1210/jcem.85.12.7167. View

Ergun-Longmire B, Mertens A, Mitby P, Qin J, Heller G, Shi W . Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab. 2006; 91(9):3494-8. DOI: 10.1210/jc.2006-0656. View

Hanada T, Toshinai K, Kajimura N, Nara-Ashizawa N, Tsukada T, Hayashi Y . Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells. Biochem Biophys Res Commun. 2003; 301(2):275-9. DOI: 10.1016/s0006-291x(02)03028-0. View

Malendowicz W, Ziolkowska A, Szyszka M, Kwias Z . Elevated blood active ghrelin and unaltered total ghrelin and obestatin concentrations in prostate carcinoma. Urol Int. 2009; 83(4):471-5. DOI: 10.1159/000251190. View

Yoshimoto A, Mori K, Sugawara A, Mukoyama M, Yahata K, Suganami T . Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol. 2002; 13(11):2748-52. DOI: 10.1097/01.asn.0000032420.12455.74. View

Feigelson H, Teras L, Diver W, Tang W, Patel A, Stevens V . Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II. Breast Cancer Res. 2008; 10(4):R57. PMC: 2575528. DOI: 10.1186/bcr2114. View

Gonzalez-Rey E, Chorny A, Delgado M . Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology. 2006; 130(6):1707-20. DOI: 10.1053/j.gastro.2006.01.041. View

Zub-Pokrowiecka A, Rembiasz K, Konturek S, Budzynski A, Konturek P, Budzynski P . Ghrelin in diseases of the gastric mucosa associated with Helicobacter pylori infection. Med Sci Monit. 2010; 16(10):CR493-500. View

Korbonits M, Goldstone A, Gueorguiev M, Grossman A . Ghrelin--a hormone with multiple functions. Front Neuroendocrinol. 2004; 25(1):27-68. DOI: 10.1016/j.yfrne.2004.03.002. View

10.

Nass R, Gaylinn B, Rogol A, Thorner M . Ghrelin and growth hormone: story in reverse. Proc Natl Acad Sci U S A. 2010; 107(19):8501-2. PMC: 2889295. DOI: 10.1073/pnas.1002941107. View

11.

Child C, Conroy D, Zimmermann A, Woodmansee W, Erfurth E, Robison L . Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study. Eur J Endocrinol. 2015; 172(6):779-90. DOI: 10.1530/EJE-14-1123. View

12.

Holmer H, Pozarek G, Wirfalt E, Popovic V, Ekman B, Bjork J . Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma. J Clin Endocrinol Metab. 2010; 95(12):5395-402. DOI: 10.1210/jc.2010-0993. View

13.

Delporte C . Structure and physiological actions of ghrelin. Scientifica (Cairo). 2014; 2013:518909. PMC: 3863518. DOI: 10.1155/2013/518909. View

14.

DOnghia V, Leoncini R, Carli R, Santoro A, Giglioni S, Sorbellini F . Circulating gastrin and ghrelin levels in patients with colorectal cancer: correlation with tumour stage, Helicobacter pylori infection and BMI. Biomed Pharmacother. 2007; 61(2-3):137-41. DOI: 10.1016/j.biopha.2006.08.007. View

15.

DeBoer M, Zhu X, Levasseur P, Meguid M, Suzuki S, Inui A . Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology. 2007; 148(6):3004-12. DOI: 10.1210/en.2007-0016. View

16.

Sadjadi A, Yazdanbod A, Lee Y, Boreiri M, Samadi F, Alizadeh B . Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis. PLoS One. 2013; 8(9):e74440. PMC: 3787044. DOI: 10.1371/journal.pone.0074440. View

17.

Corbetta S, Peracchi M, Cappiello V, Lania A, Lauri E, Vago L . Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma. J Clin Endocrinol Metab. 2003; 88(7):3117-20. DOI: 10.1210/jc.2002-021842. View

18.

Trivin C, Busiah K, Mahlaoui N, Recasens C, Souberbielle J, Zerah M . Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index. BMC Pediatr. 2009; 9:24. PMC: 2675525. DOI: 10.1186/1471-2431-9-24. View

19.

Baatar D, Patel K, Taub D . The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol. 2011; 340(1):44-58. DOI: 10.1016/j.mce.2011.04.019. View

20.

Soriano-Guillen L, Barrios V, Campos-Barros A, Argente J . Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr. 2004; 144(1):36-42. DOI: 10.1016/j.jpeds.2003.10.036. View